1. Home
  2. PRSU vs DBVT Comparison

PRSU vs DBVT Comparison

Compare PRSU & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pursuit Attractions and Hospitality Inc.

PRSU

Pursuit Attractions and Hospitality Inc.

HOLD

Current Price

$55.32

Market Cap

1.1B

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$15.67

Market Cap

948.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSU
DBVT
Founded
1926
2002
Country
United States
France
Employees
2100
90
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
948.8M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PRSU
DBVT
Price
$55.32
$15.67
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$31.67
$32.04
AVG Volume (30 Days)
331.8K
302.7K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.26
EPS
N/A
N/A
Revenue
N/A
$5,636,000.00
Revenue This Year
$4.85
$35.04
Revenue Next Year
$4.94
$2,360.78
P/E Ratio
$3.45
N/A
Revenue Growth
N/A
35.77
52 Week Low
$27.92
$8.51
52 Week High
$56.52
$26.19

Technical Indicators

Market Signals
Indicator
PRSU
DBVT
Relative Strength Index (RSI) 81.80 40.22
Support Level $33.05 $12.63
Resistance Level N/A $17.78
Average True Range (ATR) 1.55 1.09
MACD 0.41 0.07
Stochastic Oscillator 87.55 17.79

Price Performance

Historical Comparison
PRSU
DBVT

About PRSU Pursuit Attractions and Hospitality Inc.

Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, Iceland and Costa Rica. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: